Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
formulary
Pharma
Indivior signs $600M deal to settle opioid marketing accusations
Indivior will pay $600 million to settle criminal and civil marketing allegations, including claims that it downplayed Suboxone's risk to children.
Kyle Blankenship
Jul 27, 2020 12:23pm
UnitedHealthcare backs Amgen biosims over Roche's oncology meds
Aug 16, 2019 10:55am
Novo’s oral semaglutide could disrupt diabetes coverage: analyst
Mar 5, 2019 12:05pm
CVS sidelines Amgen's Aimovig in favor of Teva, Lilly CGRP drugs
Jan 28, 2019 11:45am
Biogen, Teva benefit as payers ease up on MS meddling: analyst
Aug 30, 2018 12:25pm
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead
Aug 7, 2018 12:29pm